[go: up one dir, main page]

AU2001261007A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents

Compositions and methods for the therapy and diagnosis of lung cancer

Info

Publication number
AU2001261007A1
AU2001261007A1 AU2001261007A AU6100701A AU2001261007A1 AU 2001261007 A1 AU2001261007 A1 AU 2001261007A1 AU 2001261007 A AU2001261007 A AU 2001261007A AU 6100701 A AU6100701 A AU 6100701A AU 2001261007 A1 AU2001261007 A1 AU 2001261007A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261007A
Inventor
Paul A. Algate
Darin R. Benson
Mark Elliot
Steven P. Fling
Robert A. Henderson
Carol Yoseph Indirias
Michael D. Kalos
Michael J. Lodes
Jane Mannion
Raodoh Mohamath
Steven G Reed
Heather Secrist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/738,973 external-priority patent/US20020110563A1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001261007A1 publication Critical patent/AU2001261007A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001261007A 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer Abandoned AU2001261007A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US53803700A 2000-03-29 2000-03-29
US09/538,037 2000-03-29
US58893700A 2000-06-05 2000-06-05
US09/588,937 2000-06-05
US64087800A 2000-08-18 2000-08-18
US09/640,878 2000-08-18
US23451700P 2000-09-22 2000-09-22
US60/234,517 2000-09-22
US70451200A 2000-11-01 2000-11-01
US09/704,512 2000-11-01
US09/738,973 2000-12-14
US09/738,973 US20020110563A1 (en) 2000-11-01 2000-12-14 Compositions and methods for the therapy and diagnosis of lung cancer
PCT/US2001/009991 WO2001072295A2 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
AU2001261007A1 true AU2001261007A1 (en) 2001-10-08

Family

ID=27559252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261007A Abandoned AU2001261007A1 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Country Status (7)

Country Link
JP (1) JP2004526401A (en)
AU (1) AU2001261007A1 (en)
CA (1) CA2404233A1 (en)
CZ (1) CZ20023567A3 (en)
HU (1) HUP0500345A2 (en)
PL (1) PL366626A1 (en)
WO (1) WO2001072295A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082212A1 (en) * 2000-07-20 2002-06-27 Millennium Pharmaceuticals, Inc. 7716, a novel human ATPase and uses therefor
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
WO2002092001A2 (en) * 2001-05-11 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2004035789A1 (en) * 2002-10-18 2004-04-29 Lg Life Sciences Ltd. Gene families associated with cancers
DE10258051A1 (en) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Use of substances that bind to HAT for the diagnosis and treatment of squamous cell carcinoma of the lungs
AU2003295189A1 (en) * 2002-12-17 2004-07-09 Fondazione Centro San Raffaele Del Monte Tabor Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof
AU2003292696A1 (en) 2002-12-26 2004-08-10 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
PE20091567A1 (en) 2004-06-25 2009-11-03 Takeda Pharmaceutical METASTINE DERIVATIVES IN THE TREATMENT OF CANCER
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
AR058584A1 (en) 2005-12-22 2008-02-13 Takeda Pharmaceutical METASTININE DERIVATIVES AND USE OF THE SAME
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JP2007263896A (en) * 2006-03-29 2007-10-11 Univ Nagoya Biomarker and method for predicting postoperative prognosis of lung cancer patients
JO3048B1 (en) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co Metastin Derivatives And Use Thereof
JP5648261B2 (en) * 2006-12-20 2015-01-07 東レ株式会社 Cancer detection method
PL2322221T3 (en) 2008-08-05 2015-01-30 Toray Industries Pharmaceutical composition for treatment and prevention of cancer
MX337991B (en) * 2008-08-05 2016-03-30 Toray Industries Cancer detection method.
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US8883966B2 (en) 2008-10-22 2014-11-11 Oncotherapy Science, Inc. RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
KR101842893B1 (en) 2010-02-04 2018-03-28 도레이 카부시키가이샤 Pharmaceutical composition for treatment and/or prevention of cancer
AU2011211682B2 (en) 2010-02-04 2015-08-13 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
JP5906739B2 (en) 2010-02-04 2016-04-20 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
KR101843807B1 (en) 2010-02-04 2018-03-30 도레이 카부시키가이샤 Pharmaceutical agent for treatment and/or prevention of cancer
JP5845899B2 (en) 2010-02-04 2016-01-20 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
PT2532366T (en) 2010-02-04 2016-12-20 Toray Industries Pharmaceutical composition for treating and/or preventing cancer
BR112014002616B1 (en) 2011-08-04 2022-01-18 Toray Industries, Inc METHOD TO DETECT PANCREATIC CANCER
WO2013018891A1 (en) 2011-08-04 2013-02-07 東レ株式会社 Pharmaceutical composition for treatment and/or prophylaxis of cancer
EP3351630B1 (en) 2011-08-04 2019-10-16 Toray Industries, Inc. Pharmaceutical composition comprising anti caprin-1 antibodies for treating and/or preventing cancer
EP2740798B1 (en) 2011-08-04 2016-12-07 Toray Industries, Inc. Cancer treatment and/or prevention drug composition
DK2740793T3 (en) 2011-08-04 2018-01-22 Toray Industries PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND / OR PREVENTION
PT2740489T (en) 2011-08-04 2017-01-10 Toray Industries Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
PT2740795T (en) 2011-08-04 2017-01-09 Toray Industries Cancer treatment and/or prevention drug composition
JP6187256B2 (en) 2012-02-21 2017-08-30 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
CA2865020C (en) 2012-02-21 2021-01-26 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
AU2013223137B2 (en) 2012-02-21 2017-10-19 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
ES2739612T3 (en) 2012-02-21 2020-02-03 Toray Industries Pharmaceutical composition for cancer treatment
CN104220095B (en) 2012-03-30 2016-09-07 东丽株式会社 The treatment of liver cancer and/or prophylactic compositions
MX357965B (en) 2012-03-30 2018-08-01 Toray Industries Pharmaceutical composition for treatment and/or prevention of gall bladder cancer.
WO2014014086A1 (en) 2012-07-19 2014-01-23 東レ株式会社 Cancer detection method
MX357292B (en) 2012-07-19 2018-07-04 Toray Industries Cancer detection method.
HUE042081T2 (en) 2013-08-09 2019-06-28 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
AU4185100A (en) * 1999-04-02 2000-10-23 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001253594A1 (en) * 2000-04-17 2001-10-30 Pharmacia And Upjohn Company Novel g protein-coupled receptors
AU2001259322A1 (en) * 2000-05-03 2001-11-12 Pharmacia And Upjohn Company G protein-coupled receptors
AU2001269766A1 (en) * 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
WO2001072295A3 (en) 2002-08-22
PL366626A1 (en) 2005-02-07
WO2001072295A2 (en) 2001-10-04
JP2004526401A (en) 2004-09-02
CA2404233A1 (en) 2001-10-04
CZ20023567A3 (en) 2003-11-12
HUP0500345A2 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003230849A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer